FDA Approves Qelbree

FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment […]

Read more

FDA Approves Nulibry

FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) […]

Read more

FDA Approves Pepaxto

FDA Approves Pepaxto (melphalan flufenamide) for Patients with Relapsed or Refractory Multiple Myeloma STOCKHOLM, Feb. 26, 2021 /PRNewswire/ — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused […]

Read more

FDA Approves Evkeeza

FDA Approves Evkeeza (evinacumab-dgnb) for Patients with Homozygous Familial Hypercholesterolemia TARRYTOWN, N.Y., Feb. 11, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug […]

Read more

FDA Approves Ukoniq

FDA Approves Ukoniq (umbralisib) for Marginal Zone Lymphoma and Follicular Lymphoma NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the U.S. Food and […]

Read more

Chirocaine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHIROCAINE SOLUTION FOR INJECTION & CONCENTRATED SOLUTION FOR INFUSION levobupivacaine 25mg/10mL, 50mg/10mL, 75 mg/10mL, 62.5mg/100mL*, 125mg/100mL*, 250mg/200mL […]

Read more

Ventolin Obstetric Injection

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Ventolin® Obstetric Injection Salbutamol sulfate Consumer Medicine Information What is in this leaflet This leaflet answers some […]

Read more

Leustatin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LEUSTATIN® Injection Cladribine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions […]

Read more

Entecavir APOTEX

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ENTECAVIR APOTEX TABLETS Contains the active ingredient entecavir monohydrate Consumer Medicine Information What is in this leaflet […]

Read more
1 2 3 13